|
HS Code |
856201 |
| Name | Bromisoval |
| Chemical Formula | C6H11BrN2O2 |
| Molecular Weight | 223.07 g/mol |
| Iupac Name | 5-bromo-5-isovaleroylbarbituric acid |
| Cas Number | 496-67-3 |
| Appearance | White crystalline powder |
| Melting Point | 133-135 °C |
| Solubility In Water | Slightly soluble |
| Route Of Administration | Oral |
| Atc Code | N05CM03 |
| Synonyms | Bromovalerylurea, Broval |
| Legal Status | Controlled substance in some countries |
| Side Effects | Drowsiness, skin eruptions, respiratory depression |
As an accredited Bromisoval factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | A 100-gram amber glass bottle labeled "Bromisoval," featuring hazard symbols, batch number, manufacturer details, and tightly sealed with a screw cap. |
| Shipping | Bromisoval should be shipped as a hazardous material, compliant with relevant regulations (such as IATA, IMDG, or DOT). Use secure, tightly sealed packaging, clearly labeled with appropriate hazard warnings. Store and transport in a cool, dry environment, protected from heat, light, and incompatible substances. Handle only by trained personnel wearing proper protective equipment. |
| Storage | Bromisoval should be stored in a tightly sealed container, protected from light, moisture, and incompatible substances such as strong oxidizers. Keep it in a cool, dry, and well-ventilated area, away from sources of ignition or heat. Ensure that storage areas are secure and clearly labeled. Follow all local regulations concerning the storage and handling of chemicals. |
Applications of Bromisoval in Industrial ManufacturingAs a primary producer of Bromisoval, we supply the pharmaceutical and specialty chemical sectors where this material serves as a critical, tightly regulated intermediate. Below, we detail the primary industrial applications according to established compliance frameworks, process control requirements, and industrial usage data. Each segment highlights technical requirements and downstream integration for manufacturers seeking trusted, application-specific sourcing. 1. Hypnotic and Sedative Pharmaceutical IntermediateThe primary application of Bromisoval resides in its use as an active intermediate for the large-scale production of hypnotic and sedative drugs. This segment requires close adherence to pharmaceutical-grade purity and rigorous impurity control, demanded by internationally harmonized pharmacopoeias. R&D and manufacturing teams rely on adjustable input concentrations to precisely control the pharmacokinetic profile in the synthesis of final-tablet or injectable forms. Upstream introduction of the raw material occurs during multi-stage organic synthesis steps, where the input is calibrated to the yield demands and purity targets of the downstream workflow. Finished goods in this application enter regulated distribution channels as Rx sedative and hypnotic tablets, ampoules, or oral liquid forms. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Veterinary Sedative and Euthanasia Agent PrecursorVeterinary pharmaceutical producers utilize Bromisoval in sedative and anesthetic product development, focused primarily on companion animal and livestock care. Formulation is highly regulated, conforming to region-specific veterinary compendiums and residue control mandates. Careful weight-based ratio adjustment is required to optimize therapeutic index and minimize adverse effects in target species. The material is dosed into controlled fusion or granulation stages depending on the final dosage form. Downstream products are supplied as veterinary prescription tablets, injectable doses, or oral pastes for animal hospitals and agricultural customers. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Intermediate for Specialized Agrochemical CompoundsCertain niche agrochemical formulations incorporate Bromisoval as an intermediate to produce regulated compounds for pest management, under strict chemical handling protocols. Strict traceability and environmental protection controls govern this application, with all manufacturing operations subject to local agricultural substance regulations and international transport codes. The loading ratio depends on conversion efficiency and reaction yield optimization, adjusted to meet the residual limits set by food safety agencies. The compound is introduced at early-stage synthesis and is fully consumed during active ingredient formation, supporting closed-loop batch production. Finished agrochemical products include select soil or seed treatment compounds, destined for restricted agricultural use. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Laboratory Reagent in Analytical Chemistry and SynthesisChemical analysis and R&D laboratories source Bromisoval as a specialty reagent for structure-activity relationship studies, synthesis route validation, and reference compound preparation. This segment demands ACS reagent or pharmaceutical grade, with full documentation of batch traceability and impurity analysis. Usage quantities remain strictly regulated per validated protocols or method requirements, especially in institutions governed by laboratory accreditation schemes. Integration occurs during organic synthesis procedure testing or as a matrix-matched analytical standard in bioanalytical research. The downstream outcome includes validated calibration standards, reference substances, or analytical sample solutions for regulated chemical laboratories. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Bromisoval prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Our team approaches Bromisoval with decades of hands-on experience from lab benches and production lines all the way to industrial-scale batches. As direct manufacturers, we navigate the landscape of raw materials, synthesis routes, and every fluctuation in production conditions ourselves. Bromisoval stands as a product shaped by real-world demands and refined by consistent experimentation, not just theory from textbooks. Laboratories, pharmaceutical developers, and research institutes regularly look to Bromisoval for dependable quality because every step is in our own hands, from raw feedstock selection to packaging.
Bromisoval commonly arrives as a crystalline white powder—distinct, not chalky or gray. We pay close attention to purity, moisture content, and particle size, since consistency in these areas means fewer unknowns downstream. Purity routinely surpasses 99%, tightening process tolerances in any application requiring stability. The melting point, which falls consistently within the 130–135°C range, signals that no byproducts remain from synthesis or post-processing. Each batch reaches this mark under repeatable test conditions. Water content remains below 0.5%, which helps prevent degradation and ensures predictable shelf life.
Our experience reminds us that even a small deviation during synthesis causes off-spec product or unexpected behavior in critical applications. Each specification comes from years of customer feedback and our own troubleshooting on the factory floor. Particle size uniformity, verified using sieves and laser diffraction, ensures the product dissolves as expected and blends smoothly without clumping. The outcome—a standard that chemists trust, not just an average pulled from literature or third-party sources.
Bromisoval fills a precise role for chemists, especially in pharmaceutical research and organic synthesis. Historically, it served as a sedative—though modern medicine rarely prescribes it for humans, and the industry recognizes its risks when misused. Still, its value remains significant in laboratory protocols, where researchers study barbiturate analogs and CNS depressants. Veterinary practitioners in some regions continue to rely on it to induce short-term sedation in animals during certain procedures, using doses defined by strict guidelines and experience.
Beyond pharmacology, Bromisoval serves as an intermediate in the synthesis of more complex organic molecules. Specialists choose it because they understand the importance of reliable halogenated intermediates that react in predictable ways. Certain reactions demand a compound that offers a stable, well-defined leaving group; Bromisoval’s bromine atom and ureide structure provide those traits. As manufacturers, we have collaborated on numerous process development trials to help customers ensure that yields remain consistent, waste is minimized, and purification steps go smoothly once Bromisoval enters the reaction vessel. This is not a commodity chemical you can swap out for just anything else—success hinges on consistent quality and thorough support during process integration.
Manufacturing experience teaches respect for chemicals with sedative or CNS effects. Bromisoval requires strict control, both for regulatory reasons and to prevent workplace mishaps. We maintain dedicated containment areas and distinct handling protocols—choices driven by daily practice, not just rules on paper. The faint, characteristic odor signals its presence early; training ensures those in the area recognize it quickly. Our operator teams use protective equipment and avoid unnecessary exposure, because familiarity breeds neither carelessness nor complacency.
Disposal, too, follows well-practiced routines. Solutions containing Bromisoval run through neutralization and analytical checks before leaving the site. Detailed batch traceability prevents any confusion or accidental mixing with substances destined for other processes. Storage conditions—cool, dry, away from direct sunlight—reflect our commitment to maintaining stability right up to the moment the drum is opened. Even after years, we see firsthand how correct storage extends shelf life and preserves product quality, reducing complaints and reruns.
The market does not lack for brominated intermediates and sedative barbiturates. Yet, only manufacturers rooted in daily process control can promise a product that eliminates guesswork for end users. We do not cut corners with raw material suppliers. Each batch receives quality checks at multiple points, allowing for early intervention if anything veers from the standard. It’s a simple truth—if contamination sneaks in, or if a drying oven drifts a few degrees, the result fails our standards before it ever reaches the customer.
Direct manufacturing oversight gives us insight into subtle trends: supply chain disruptions affecting bromine availability, for example, or evolving waste disposal regulations that change acceptable production routes. We adapt processes rapidly because we control them end-to-end, not through third-party contractors who may not understand the implications of a minor variables change.\
Differences from more generic or repackaged Bromisoval often surface after delivery—sometimes as mysterious impurities, sometimes as inconsistent crystallinity, or abnormal handling properties. Long-standing relationships with our clients mean we hear about these issues directly and resolve them—often by reworking lots or revisiting upstream stages rather than shifting blame. This sets us apart from traders or middlemen focused solely on margins and volume. We value stability and reproducibility over quick turnarounds.
One rarely stated advantage of direct manufacturing is transparency. Any customer working with us has access to our test data, can audit our processes, and gets clear answers from the chemists and engineers who ran the batches. If a research project calls for atypical specifications—say, a different particle size or a tailored moisture range—our production managers review the request for feasibility. They reach conclusions based on actual plant capabilities, not wishful thinking or marketing promises. In practice, this keeps expectations and outcomes aligned, whether for large-scale pharmaceutical development or small-volume laboratory research.
Over time, processes evolve. Regulatory pressures, equipment upgrades, and customer feedback loop back to change how Bromisoval gets made. We were among the first to implement real-time monitoring for key process variables, catching deviations before they cascade into off-spec material. Our plant operators, some with thirty years’ tenure, spot subtle clues—a shift in crystallization speed, a change in odor, minor color changes—that no automated system catches alone. Their experience shapes our quality standards as much as any written protocol.
We invest in waste minimization, solvent recovery, and process safety, not because it looks good on a brochure, but because plant incidents and resource loss cut deeply into productivity. Government inspectors walk our floors regularly; their questions keep us honest but rarely surprise us. We plan for these audits with as much care as for customer shipments. We also engage regularly with professional societies and regulatory update forums, bringing back knowledge that makes its way into both documentation and actual plant layouts.
One lesson stands out: assumptions made in the office often break down on the production floor. That’s why we maintain a culture of open communication between R&D, production, and customer-facing staff. If a customer calls with an issue, our chemists discuss the possible causes based on years of seeing how real batches behave—not just textbook answers. Every nonconformance gets treated not as a paperwork burden, but as a chance to fix root causes so recurrences dwindle over time. Employee feedback, gathered from daily close-out meetings and quarterly reviews, keeps process documents grounded in current reality, not three-year-old theory.
Bromisoval’s history demands respect for both its benefits and the risks attached. As a sedative, the molecule made significant contributions to medicine and research. Yet the risk of dependency and misuse shapes our approach as stewards of this chemistry. We comply with local and national regulations for controlled chemicals, never turning a blind eye to suspicious requests or unusual order patterns. Our staff receive ongoing training to recognize misuse risks and prioritize compliance as a matter of professional pride, not bureaucratic hassle.
Community responsibility extends beyond legal compliance. Our facilities run extensive air and water monitoring to prevent neighborhood impact. Years ago, feedback from nearby residents led us to invest in additional filtration and noise-reduction barriers, not waiting for regulatory mandates. These investments pay off not just in smoother relations, but also in greater pride among our staff. Our company participates in local chemical safety workshops, providing expertise and resources where we can, acknowledging that everyone benefits from responsible production, not just our downstream customers.
We also pay attention to the upstream supply chain: wherever possible, we source bromine and related reagents from certified partners who have similarly robust safety, sustainability, and labor practices. This reduces the risk of unwanted impurities, supports responsible chemical stewardship industry-wide, and avoids the headaches caused by poor-quality incoming materials.
Our staff routinely builds long-term relationships with academic groups, contract manufacturers, and pharmaceutical innovators. Bromisoval often sits at sensitive points in projects that cannot afford random supply or quality shifts. We engage in technical consultations not merely to fill out purchase orders, but to help engineers and bench chemists achieve laboratory-to-pilot scale-up smoothly. Questions regarding reactivity, compatibility, or alternative synthetic approaches are not shunted to generic helplines. Our team draws on production records, analytical archives, and lessons learned in prior collaborations to give meaningful guidance.
We encourage open feedback from customers, knowing that challenges in their processes reveal areas for us to strengthen. Whether it’s an analytical technique that better uncovers trace impurities, or a shipment packaging modification for easier handling at their facility, these improvements flow both ways. Visits to our facility are always welcome—for audits, troubleshooting, or joint process development—because transparency solves problems long before they snowball.
We support both standard and specialty packaging formats, accommodating needs for laboratory sampling, intermediate-scale production, and large commercial lots. Each order includes a certificate of analysis, and, if requested, additional analytical data—provided without runaround or extra charges. By handling all labeling and documentation in compliance with current shipping and material standards, we help customers clear customs or internal checks with confidence.
Every container we ship traces its journey from raw feedstock lot to final drum, logged in a system that our production and quality assurance staff access daily. If an issue ever surfaces—whether a batch test indicates off-target moisture, or a customer lab detects an unexpected impurity—we can pinpoint where, when, and how the material was processed. This immediacy has prevented many issues from spinning out of control, particularly in time-sensitive situations such as a pharmaceutical release or regulatory inspection.
Traceability does more than protect against mishaps; it allows for more informed decisions about process changes. If a newer drying technique or filtration approach improves yield without sacrificing quality, trial batches carry clear tags that let researchers compare performance in downstream applications. We hold onto these records long-term, recognizing that sometimes even minor process tweaks have ripple effects that only become clear months or years later in product performance or regulatory reporting.
Although newer sedatives and anesthetics have largely replaced Bromisoval in clinical medicine, it remains a staple in specialized research and some veterinary practices. Its structure enables unique reactions that serve as gateways to more elaborate molecules—reactions that cannot simply substitute another compound. Universities and contract research organizations run intensive screening on analogs for CNS-related studies, relying on Bromisoval’s consistency to ensure the integrity of their results.
The broader story of Bromisoval reflects many lessons in chemical manufacturing: adaptation to changing regulatory climates, harnessing technical progress, and never underestimating the importance of customer feedback. From our perspective, direct accountability, open channels of communication, and relentless attention to process control turn what seems like an ordinary chemical into an asset for researchers around the world.
Reliable products come from companies that control every detail themselves. For us, Bromisoval stands as proof that manufacturing builds trust from the ground up—batch by batch, delivery by delivery, year after year. Every shipment leaves our facility reflecting the knowledge, caution, and commitment of a team that understands success in chemistry never comes by accident.